Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2PReaoA
via IFTTT